ARTL (Artelo Biosciences, Inc. Common Stock) Stock Analysis - Analyst Ratings

Artelo Biosciences, Inc. Common Stock (ARTL) is a publicly traded Healthcare sector company. As of May 21, 2026, ARTL trades at $1.46 with a market cap of $3.19M and a P/E ratio of 0.00. ARTL moved +3.68% today. Year to date, ARTL is -63.59%; over the trailing twelve months it is -91.84%. Its 52-week range spans $1.25 to $85.80. Rallies surfaces ARTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate ARTL?

The average price target is $0.00.

ARTL Key Metrics

Key financial metrics for ARTL
MetricValue
Price$1.46
Market Cap$3.19M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$85.80
52-Week Low$1.25
Volume9.16K
Avg Volume0
Revenue (TTM)$0
Net Income$-9.83M
Gross Margin0.00%

ARTL Analyst Consensus

ARTL analyst coverage data. Average price target: $0.00.

Latest ARTL News

Recent ARTL Insider Trades

  • Gorgas Gregory D. bought 1.20K (~$4.80K) on Aug 12, 2022.
  • Gorgas Gregory D. bought 1.20K (~$4.84K) on Aug 11, 2022.

Common questions about ARTL

What do analysts rate ARTL?
The average price target is $0.00.
Does Rallies show ARTL price targets?
Yes. Rallies tracks ARTL analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is ARTL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARTL. It does not provide personalized investment advice.
ARTL

ARTL